ADN: Advent Technologies Holdings Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Advent Technologies Holdings Inc (ADN).

OverviewDividends

$13.18M Market Cap.

As of 06/06/2025 5:00 PM ET (MRY) • Disclaimer

ADN Market Cap. (MRY)


ADN Shares Outstanding (MRY)


ADN Assets (MRY)


Total Assets

$8.01M

Total Liabilities

$29.30M

Total Investments

$0

ADN Income (MRY)


Revenue

$3.28M

Net Income

-$40.99M

Operating Expense

$20.16M

ADN Cash Flow (MRY)


CF Operations

-$6.61M

CF Investing

$1.17M

CF Financing

$1.39M

ADN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$8,007,000 (-76.95%)

$34,737,000 (-61.23%)

$89,588,000 (-45.05%)

$163,031,000 (8507.48%)

Assets Current

$2,693,000 (-69.52%)

$8,835,000 (-82.15%)

$49,500,000 (-49.15%)

$97,351,000 (5642.78%)

Assets Non-Current

$5,314,000 (-79.48%)

$25,902,000 (-35.39%)

$40,088,000 (-38.96%)

$65,680,000 (32926.10%)

Goodwill & Intangible Assets

$85,000 (7.59%)

$79,000 (-99.33%)

$11,804,000 (-77.88%)

$53,374,000 (0%)

Shareholders Equity

-$21,295,000 (-258.35%)

$13,448,000 (-79.04%)

$64,148,000 (-50.73%)

$130,201,000 (7359.71%)

Property Plant & Equipment Net

$4,912,000 (-80.17%)

$24,765,000 (12.60%)

$21,993,000 (156.18%)

$8,585,000 (4219.78%)

Cash & Equivalents

$381,000 (-89.60%)

$3,662,000 (-88.86%)

$32,869,000 (-58.79%)

$79,764,000 (15366.11%)

Accumulated Other Comprehensive Income

-$157,000 (93.27%)

-$2,334,000 (10.37%)

-$2,604,000 (-104.56%)

-$1,273,000 (-1238.84%)

Deferred Revenue

$3,831,000 (33.72%)

$2,865,000 (53.21%)

$1,870,000 (41.35%)

$1,323,000 (160.00%)

Total Investments

$0 (0%)

$750,000 (-29.91%)

$1,070,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$750,000 (-29.91%)

$1,070,000 (0%)

$0 (0%)

Inventory

$8,000 (-99.70%)

$2,707,000 (-78.55%)

$12,620,000 (81.37%)

$6,958,000 (6346.23%)

Trade & Non-Trade Receivables

$962,000 (403.66%)

$191,000 (-80.49%)

$979,000 (-68.81%)

$3,139,000 (542.13%)

Trade & Non-Trade Payables

$17,035,000 (234.87%)

$5,087,000 (8.70%)

$4,680,000 (-3.25%)

$4,837,000 (142.33%)

Accumulated Retained Earnings (Deficit)

-$220,153,000 (-22.88%)

-$179,159,000 (-66.25%)

-$107,762,000 (-222.40%)

-$33,425,000 (-159.08%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$1,246,000 (0%)

Tax Liabilities

$170,000 (-5.03%)

$179,000 (-2.19%)

$183,000 (-93.21%)

$2,696,000 (1236.11%)

Total Debt

$832,000 (-92.01%)

$10,416,000 (-13.79%)

$12,082,000 (0%)

$0 (0%)

Debt Current

$648,000 (-70.36%)

$2,186,000 (-4.12%)

$2,280,000 (0%)

$0 (0%)

Debt Non-Current

$184,000 (-97.76%)

$8,230,000 (-16.04%)

$9,802,000 (0%)

$0 (0%)

Total Liabilities

$29,302,000 (37.64%)

$21,289,000 (-16.32%)

$25,440,000 (-22.51%)

$32,830,000 (790.30%)

Liabilities Current

$28,772,000 (141.52%)

$11,913,000 (-12.83%)

$13,666,000 (-27.58%)

$18,871,000 (450.37%)

Liabilities Non-Current

$530,000 (-94.35%)

$9,376,000 (-20.37%)

$11,774,000 (-15.65%)

$13,959,000 (5294.95%)

ADN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,276,000 (-32.58%)

$4,859,000 (-38.00%)

$7,837,000 (10.86%)

$7,069,000 (700.88%)

Cost of Revenue

$1,488,000 (-91.86%)

$18,287,000 (113.11%)

$8,581,000 (58.73%)

$5,406,000 (952.12%)

Selling General & Administrative Expense

$14,318,000 (-55.90%)

$32,468,000 (-9.60%)

$35,915,000 (-14.24%)

$41,877,000 (1080.68%)

Research & Development Expense

$3,225,000 (-73.37%)

$12,112,000 (23.64%)

$9,796,000 (176.65%)

$3,541,000 (3353.35%)

Operating Expenses

$20,157,000 (-64.58%)

$56,913,000 (-32.79%)

$84,683,000 (85.00%)

$45,774,000 (1229.65%)

Interest Expense

$535,000 (822.97%)

-$74,000 (-42.31%)

-$52,000 (-201.96%)

$51,000 (820.25%)

Income Tax Expense

-$55,000 (-107.65%)

$719,000 (136.50%)

-$1,970,000 (-113.43%)

-$923,000 (0%)

Net Loss Income from Discontinued Operations

$10,980,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$40,994,000 (42.58%)

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$40,994,000 (42.58%)

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$40,994,000 (42.58%)

-$71,397,000 (3.95%)

-$74,337,000 (-262.21%)

-$20,523,000 (-557.57%)

Weighted Average Shares

$2,618,857 (36.60%)

$1,917,179 (-96.28%)

$51,528,703 (12.47%)

$45,814,868 (123.28%)

Weighted Average Shares Diluted

$2,618,857 (36.60%)

$1,917,179 (-96.28%)

$51,528,703 (12.47%)

$45,814,868 (123.28%)

Earning Before Interest & Taxes (EBIT)

-$40,514,000 (42.74%)

-$70,752,000 (7.34%)

-$76,359,000 (-256.90%)

-$21,395,000 (-586.73%)

Gross Profit

$1,788,000 (113.32%)

-$13,428,000 (-1704.84%)

-$744,000 (-144.74%)

$1,663,000 (350.88%)

Operating Income

-$18,369,000 (73.89%)

-$70,341,000 (17.66%)

-$85,427,000 (-93.66%)

-$44,111,000 (-1335.10%)

ADN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$1,173,000 (118.82%)

-$6,234,000 (57.06%)

-$14,517,000 (43.20%)

-$25,556,000 (-20760.68%)

Net Cash Flow from Financing

$1,393,000 (-84.62%)

$9,059,000 (22747.50%)

-$40,000 (-100.03%)

$141,501,000 (15937.20%)

Net Cash Flow from Operations

-$6,613,000 (79.41%)

-$32,115,000 (0.03%)

-$32,125,000 (10.36%)

-$35,837,000 (-2414.76%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,669,000 (87.47%)

-$29,290,000 (37.26%)

-$46,682,000 (-158.27%)

$80,108,000 (12141.86%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$1,864,000 (0%)

$0 (0%)

-$19,425,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$316,000 (0%)

$0 (0%)

Capital Expenditure

$1,258,000 (128.79%)

-$4,370,000 (68.97%)

-$14,084,000 (-130.39%)

-$6,113,000 (-4889.88%)

Issuance (Repayment) of Debt Securities

$559,000 (0%)

$0 (0%)

-$40,000 (-133.90%)

$118,000 (123.60%)

Issuance (Purchase) of Equity Shares

$291,000 (-96.79%)

$9,059,000 (0%)

$0 (0%)

$141,383,000 (296655.85%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$378,000 (355.42%)

$83,000 (-84.54%)

$537,000 (162.44%)

-$860,000 (-4668.51%)

Share Based Compensation

$3,783,000 (-61.71%)

$9,881,000 (-5.12%)

$10,414,000 (35.09%)

$7,709,000 (786.62%)

Depreciation Amortization & Accretion

$1,593,000 (-56.32%)

$3,647,000 (-14.33%)

$4,257,000 (144.09%)

$1,744,000 (7648.36%)

ADN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

54.60% (119.75%)

-276.40% (-2809.47%)

-9.50% (-140.43%)

23.50% (-43.78%)

Profit Margin

-1251.30% (14.84%)

-1469.40% (-54.92%)

-948.50% (-226.73%)

-290.30% (17.90%)

EBITDA Margin

-1188.10% (13.97%)

-1381.00% (-50.11%)

-920.00% (-230.94%)

-278.00% (20.66%)

Return on Average Equity (ROAE)

453.40% (324.12%)

-202.30% (-184.53%)

-71.10% (-318.24%)

-17.00% (89.58%)

Return on Average Assets (ROAA)

-265.10% (-118.01%)

-121.60% (-105.41%)

-59.20% (-335.29%)

-13.60% (-312.12%)

Return on Sales (ROS)

-1236.70% (15.07%)

-1456.10% (-49.45%)

-974.30% (-221.87%)

-302.70% (14.25%)

Return on Invested Capital (ROIC)

1041.80% (727.21%)

-166.10% (40.29%)

-278.20% (1.28%)

-281.80% (-204.68%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.32 (-78.21%)

-0.18 (85.76%)

-1.26 (91.93%)

-15.58 (84.35%)

Price to Sales Ratio (P/S)

4 (51.57%)

2.64 (-77.84%)

11.9 (-73.80%)

45.43 (-86.91%)

Price to Book Ratio (P/B)

-0.62 (-159.75%)

1.04 (-28.99%)

1.46 (-47.12%)

2.76 (102.27%)

Debt to Equity Ratio (D/E)

-1.38 (-186.92%)

1.58 (298.74%)

0.4 (57.54%)

0.25 (112.26%)

Earnings Per Share (EPS)

-15.65 (57.98%)

-37.24 (-2486.11%)

-1.44 (-220.00%)

-0.45 (-200.00%)

Sales Per Share (SPS)

1.25 (-50.63%)

2.53 (1567.11%)

0.15 (-1.30%)

0.15 (258.14%)

Free Cash Flow Per Share (FCFPS)

-2.04 (89.25%)

-19.03 (-2021.63%)

-0.9 (2.07%)

-0.92 (-1121.33%)

Book Value Per Share (BVPS)

-8.13 (-215.93%)

7.01 (463.37%)

1.25 (-56.19%)

2.84 (3366.67%)

Tangible Assets Book Value Per Share (TABVPS)

3.02 (-83.27%)

18.08 (1097.22%)

1.51 (-36.90%)

2.39 (2501.09%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (91.67%)

-12 (42.86%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.34 (-17.99%)

-0.29 (59.30%)

-0.71 (94.77%)

-13.58 (36.40%)

Asset Turnover

0.21 (155.42%)

0.08 (33.87%)

0.06 (31.91%)

0.05 (422.22%)

Current Ratio

0.09 (-87.33%)

0.74 (-79.51%)

3.62 (-29.79%)

5.16 (944.33%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$5,355,000 (85.32%)

-$36,485,000 (21.04%)

-$46,209,000 (-10.15%)

-$41,950,000 (-2610.69%)

Enterprise Value (EV)

$13,260,540 (-31.53%)

$19,366,958 (-62.15%)

$51,163,073 (-80.82%)

$266,795,306 (304.04%)

Earnings Before Tax (EBT)

-$41,049,000 (41.92%)

-$70,678,000 (7.38%)

-$76,307,000 (-255.81%)

-$21,446,000 (-587.14%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$38,921,000 (42.00%)

-$67,105,000 (6.93%)

-$72,102,000 (-266.91%)

-$19,651,000 (-535.34%)

Invested Capital

-$20,399,000 (-169.15%)

$29,499,000 (-31.92%)

$43,331,000 (293.13%)

$11,022,000 (637.54%)

Working Capital

-$26,079,000 (-747.27%)

-$3,078,000 (-108.59%)

$35,834,000 (-54.34%)

$78,480,000 (4626.99%)

Tangible Asset Value

$7,922,000 (-77.14%)

$34,658,000 (-55.44%)

$77,784,000 (-29.07%)

$109,657,000 (5689.52%)

Market Capitalization

$13,182,540 (-5.38%)

$13,931,958 (-85.12%)

$93,609,073 (-73.95%)

$359,287,673 (65.12%)

Average Equity

-$9,042,250 (-125.62%)

$35,289,250 (-66.25%)

$104,569,250 (-13.17%)

$120,423,810 (6193.79%)

Average Assets

$15,464,250 (-73.67%)

$58,721,500 (-53.27%)

$125,652,750 (-16.87%)

$151,160,968 (57.83%)

Invested Capital Average

-$3,888,750 (-109.13%)

$42,589,750 (55.16%)

$27,448,750 (261.54%)

$7,592,141 (755.90%)

Shares

2,636,508 (26.49%)

2,084,374 (-95.97%)

51,717,720 (0.91%)

51,253,591 (251.67%)